NOS1 and substance withdrawal syndrome: The present research showed that chronic co-administration of NOS inhibitor L-NAME was able to retard the development of opioid tolerance/dependence, to attenuate significantly naloxone-precipitated withdrawal syndrome and to prevent the tolerance to the cardiovascular action of morphine.